ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in SRRK — Scholar Rock Holding Corp

CIK 1165408 Boston, MA

Position in SRRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$95,227,110

+$60,815,110 QoQ

Shares Held

1,731,402

+147.3% QoQ

Ownership

1.42%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#22

of 304 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. SRRK ranks #11 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	10,349,328	$366,262,717
2	PRAX	Praxis Precision Medicines, Inc.	1,015,480	$339,972,549
3	VRTX	Vertex Pharmaceuticals Inc / Ma	393,964	$195,693,737
4	TNGX	Tango Therapeutics, Inc.	5,600,000	$175,056,000
5	BBIO	BridgeBio Pharma, Inc.	2,252,000	$167,728,960
6	SYRE	Spyre Therapeutics, Inc.	1,722,300	$152,905,794
7	TVTX	Travere Therapeutics, Inc.	2,569,356	$145,965,114
8	RPRX	Royalty Pharma plc	2,500,000	$140,175,000

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$95,227,110	1,731,402	+147.3%	Shares	Sole	2026-08-14
2026-03-31	$34,412,000	700,000	-64.1%	Shares	Sole	2026-05-15
2025-09-30	$72,687,489	1,951,866	+60.6%	Shares	Sole	2025-11-14
2025-06-30	$43,035,300	1,215,000	-39.8%	Shares	Sole	2025-08-14
2025-03-31	$64,878,700	2,018,000	+26.5%	Shares	Sole	2025-05-15
2024-12-31	$68,930,238	1,594,869	+1175.9%	Shares	Sole	2025-02-14
2024-06-30	$1,041,250	125,000	-76.2%	Shares	Sole	2024-08-14
2024-03-31	$9,324,000	525,000	-59.6%	Shares	Sole	2024-05-15
2023-12-31	$24,440,000	1,300,000	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.